CN105193499A - Electric coagulation hemostasis device and traditional Chinese medicine composition used for device - Google Patents

Electric coagulation hemostasis device and traditional Chinese medicine composition used for device Download PDF

Info

Publication number
CN105193499A
CN105193499A CN201510697111.7A CN201510697111A CN105193499A CN 105193499 A CN105193499 A CN 105193499A CN 201510697111 A CN201510697111 A CN 201510697111A CN 105193499 A CN105193499 A CN 105193499A
Authority
CN
China
Prior art keywords
conductive fiber
juice
electric
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510697111.7A
Other languages
Chinese (zh)
Other versions
CN105193499B (en
Inventor
孙华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510697111.7A priority Critical patent/CN105193499B/en
Publication of CN105193499A publication Critical patent/CN105193499A/en
Application granted granted Critical
Publication of CN105193499B publication Critical patent/CN105193499B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention provides an electric coagulation hemostasis device and a traditional Chinese medicine composition used for the device. On the basis of a conventional electric coagulation hemostasis device which uses an electrode clamping part as a heating part, conductive fibers wound into clusters are added and are in direct contact with wound parts, so that an action area is enlarged; meanwhile, since the conductive fiber assembly has elasticity and is changeable in shape, the device can be applied to wounds of various shapes, and rapid and effective electric coagulation hemostasis is realized. On such basis, in order to avoid high plasma divergence caused by impedance of the conductive fiber assembly, other multi-angle adaptability improvement is carried out, so that the whole using effect of the device is improved obviously. The electric coagulation hemostasis device is relatively low in cost and easy to realize and has an outstanding popularization prospect.

Description

A kind of electric-coagulation hemostatic device and the Chinese medicine composition for this device
Technical field
The present invention relates to surgical medical technical field, relate to the hemostatic technique in operation further, be specifically related to a kind of electric-coagulation hemostatic device and the Chinese medicine composition for this device.
Background technology
In medical treatment and nursing technology, for the bleeding of body surface mainly with the direct docile of the clean article such as binder, swab stick, tighten in wound place, thus suppress wound Continuous hemorrhage, on this basis, be aided with promote wound place blood, the external used medicine of tissue fluid rapid condensation also can play anastalsis further.But it is hemorrhage for subcutaneous tissue, especially the hemorrhage of internal organs of the body is betided in surgical operation, hemostasis cannot be implemented by said method, in this case, if amount of bleeding is comparatively large, speed, then owing to lacking the means and be easy to cause danger of stopping blooding fast and effectively, cause danger even if amount of bleeding is unlikely, also easily need the operation technique in the clear visual field to impact to such as endoscopy surgery etc.
In the prior art, electric-coagulation hemostatic device is for internal organs of the body, organizes hemorrhage a kind of quick-acting haemostatic powder means, but but finds that its performance exists obvious defect in actual applications.The electric-coagulation hemostatic device of prior art is also called electric coagulation hemostasis pincers or electrocoagulation hemostatic pen, its principle is directly contacted with wound by the electrode that front end generates heat, electric heating effect is utilized to stop blooding, therefore electronic thermo-head is needed precisely to act on wound position (as shown in Figure 1), if so wound excessive or wound shape is more complicated time, therefore effect is poor owing to being difficult to cover whole wound for the electric-coagulation hemostatic device of prior art.In this case, also cannot deal with problems by means of only increasing heating head area, because excessive heating head not easily gos deep in body on the one hand, also cannot tackle wound configuration comparatively complicated situation on the other hand, simultaneously the careless slightly scald also easily causing health tissues.
In addition, the electric-coagulation hemostatic device of prior art stops blooding by means of only stretching into the execution electrical heating of wound position, if so can apply the medicine promoting hemostasis while stretching into wound, is then expected to promote haemostatic effect further.In addition, for the drug research putting on body internal hemorrhage position in prior art, many achievements have been achieved, but be exclusively used in the concertedness medicine coordinating electric coagulation hemostasis, but have no report, if can realize in this regard breaking through, then likely promote the result of use of device entirety further.
Summary of the invention
The present invention is intended to the technological deficiency for prior art, provides a kind of electric-coagulation hemostatic device, to solve the technical problem that electric-coagulation hemostatic device in prior art is difficult to the body internal hemorrhage that wound structure is more complicated effectively stop blooding.
Another technical problem that the present invention solves be by promote heating partial and wound site effective contact for the purpose of, the electrical heating material of improvement electric-coagulation hemostatic device.
The plasma that the technical problem again that the present invention solves produces when being and alleviating electric-coagulation hemostatic device work is to the potential hazard of patient.
The another technical problem that the present invention solves is the bondage fastness promoting electrode and conductive fiber.
The another technical problem that the present invention solves is to provide a kind of Chinese medicine composition that be exclusively used in above-mentioned electric-coagulation hemostatic device, that promote anastalsis, thus the haemostatic effect of further lifting device.
The another technical problem that the present invention solves promotes its haemostatic effect further on the basis of above Chinese medicine composition.
For realizing above technical purpose, the present invention by the following technical solutions:
A kind of electric-coagulation hemostatic device, comprise insertion handle, embedded pipe, electrode, conductive fiber aggregation, wherein insert handle and there is tubular housing, embedded pipe is embedded in described tubular housing, electrode one end is connected to embedded pipe bottom, conductive fiber aggregation is the dough be wound by conductive fiber, the bondage of conductive fiber aggregation is on described electrode, there is in described embedded pipe the mutually isolated absorbing cavity in space and loading chamber, absorbing cavity lower end extends to described conductive fiber aggregation place, insert on handle lower sides and there is drug row mouth, loading chamber is by described drug row mouth and insertion handle ft connection.
Preferably, described conductive fiber material is metallic fiber.
Preferably, described conductive fiber material is carbon fiber.
Preferably, the conductive coating of described conductive fiber surfaces not exclusively covers conductive fiber surfaces.
Preferably, described electrode has three, is uniformly distributed along embedded pipe lower circumference.
A kind of Chinese medicine composition of the electric-coagulation hemostatic device characterized for above-mentioned any one technical scheme, comprise the composition of following weight portion: 2 ~ 3 parts, Folium Photiniae (Folium Photiniae serrulatae) juice, Concretio Silicea Bambusae 1 ~ 2 part, 1 ~ 2 part, Rhizoma Smilacis Bockii juice, 0.5 ~ 1 part, Folium Aloe juice, 0.5 ~ 1 part, Cera Flava, ginseng juice 0.2 ~ 0.5 part, pharmagel 0.5 ~ 0.8 part, 10 parts, water.
Preferred on the basis of above-mentioned Chinese medicine composition, also comprise the Os Gallus domesticus grass juice factor of 0.1 ~ 0.2 part; Preferred further, also comprise the throat grass juice factor of 0.1 ~ 0.2 part; Preferred further, described Chinese medicine composition is grouped into by the one-tenth of following weight portion: 2.5 parts, Folium Photiniae (Folium Photiniae serrulatae) juice, Concretio Silicea Bambusae 1.5 parts, 1.5 parts, Rhizoma Smilacis Bockii juice, 0.6 part, Folium Aloe juice, 0.6 part, Cera Flava, ginseng juice 0.4 part, Os Gallus domesticus grass juice factor 0.15 part, throat grass juice factor 0.15 part, pharmagel 0.7 part, 10 parts, water.
In above technical scheme:
At prior art electric-coagulation hemostatic device using electrode clamping part as on the basis of heater block, add the conductive fiber being wound in bulk, directly wound site is contacted with it, expand active area on the one hand, due to this, conductive fiber aggregation has elasticity, shape is variable simultaneously, therefore can be used for the wound site of various shape, realize electric coagulation hemostasis fast and effectively.
On this basis, for avoiding because homogeneous the caused plasma of conductive fiber aggregation impedance is dispersed in a large number, arrange on the one hand the absorbing cavity being arranged in embedded pipe, constant absorption wound place blood is with avoid blood to be piled up in homogenization that conductive fiber aggregation place causes impedance when the device is operated; On the other hand, at the processing link in early stage of conductive fiber, ensure that conductive coating not exclusively covers conductive fiber surfaces (as shown in Figure 3), also effectively can alleviate the homogenization of impedance, and then alleviate dispersing in a large number of plasma.Above-mentioned guarantee conductive coating not exclusively covers conductive fiber surfaces, can be realized by various known electroplating technology, can be such as rush as gases at high pressure to electroplate liquid in the process performing plating, utilize microbubble to affect the homogeneity of coating, thus obtain the effect (as shown in accompanying drawing 5,6) that coating not exclusively covers.
In addition, technical solution of the present invention is also provided with the loading chamber for delivering medicament in embedded pipe, this cavity and above-mentioned absorbing cavity spatially keep isolating, the position relationship of the two can be that absorbing cavity is positioned at embedded tubular axis line position, loading chamber is in absorbing cavity periphery, thus ensures that absorbing cavity easily absorbs the blood at conductive fiber aggregation place, loading chamber is easily in communication with the outside delivering medicament.
A kind of Chinese medicine composition being exclusively used in above-mentioned electric-coagulation hemostatic device provided by the invention is delivered to wound position by above-mentioned loading chamber, utilize on the one hand this medicine to directly act on wound and promote hemostasis, can alleviate due to the existence of medicine the wound periphery that superheated causes simultaneously and scald phenomenon.Namely got rid of by absorbing cavity after in order to avoid drug conveying to wound, the present invention with the addition of a certain amount of gelatin to promote its viscosity in Traditional Chinese medicine composition formula, also promotes the binding strength of medicine and wound simultaneously.
In the selection of Chinese medicine composition effective ingredient, require that there is excellent anthemorrhagic performance on the one hand, also require that there is good heat stability simultaneously, the present invention is determined through experimentation the compositions such as Chinese photinia, Concretio Silicea Bambusae, Rhizoma Smilacis Bockii, Aloe, Cera Flava, Radix Ginseng in view of this consideration, prescription and electric-coagulation hemostatic device are given prominence to the use of anthemorrhagic performance, be easy to obtain and cost is lower simultaneously, and Herba Abri and Herba Androsaces umbellatae be added with the haemostatic effect helping further lifting device entirety.In addition, in above technical scheme, Folium Photiniae (Folium Photiniae serrulatae) juice, Rhizoma Smilacis Bockii juice, Folium Aloe juice, ginseng juice, Os Gallus domesticus grass juice factor, throat grass juice factor can be the juice (such as being obtained by pressing method) of fresh medicine, also can be the concentrated solutions that other known extracting method obtain; And Concretio Silicea Bambusae and Cera Flava refer to its powder.
Technical solution of the present invention introduces conductive fiber cleverly as heater, is effectively improved the result of use of device entirety by the improvement of other conformabilities simultaneously, simultaneously cost of the present invention lower, be easy to realize, there is outstanding promotion prospect.
Accompanying drawing explanation
Fig. 1 is the electric coagulation hemostasis wrench structure schematic diagram of prior art of the present invention;
Fig. 2 is the device perspective view of electric-coagulation hemostatic device when performing hemostasis for large wound of the embodiment of the present invention;
Fig. 3 is the partial enlarged drawing at A place in Fig. 2;
Fig. 4 be the embodiment of the present invention electric-coagulation hemostatic device for comparatively large, to perform hemostasis compared with gash time device vertical section structure schematic diagram;
Fig. 5 is the conductive fiber aggregation used by electric-coagulation hemostatic device of the present invention, the electroplating operations pattern diagram in preparation process;
Fig. 6 is the partial enlarged drawing at B place in Fig. 5;
In figure:
1, handle 2, embedded pipe 3, electrode 4, conductive fiber aggregation is inserted
5, larger wound surface 6, absorbing cavity 7, loading chamber 8, blood vessel
9, blood outlet 10, conductive fiber 11, conductive coating 12, gases at high pressure
13, pressure line 14, electroplating bath 15, electroplate liquid 16, gas distributor
17, microbubble 18, cathode wire 19, positive wire 20, electrode
21, drug row mouth 22, less wound surface
Detailed description of the invention
Below will be described in detail the specific embodiment of the present invention.In order to avoid too much unnecessary details, in the examples below to belonging to known structure or function will not be described in detail.
The approximating language used in following examples can be used for quantitative expression, shows to allow quantity to have certain variation when not changing basic function.Therefore, this exact value itself is not limited to the numerical value that the language such as " approximately ", " left and right " is revised.In certain embodiments, " approximately " represents and allows its numerical value revised to change in the positive and negative scope of 10 (10%), such as, and any numerical value that what " about 100 " represented can be between 90 to 110.In addition, in the statement of " about first numerical value is to second value ", revise the first and second numerical value two numerical value approximately simultaneously.In some cases, approximating language may be relevant with the precision of gauge.
In describing the invention, it should be noted that, unless otherwise clearly defined and limited, term " installation ", " being connected ", " connection " should be interpreted broadly, and such as, can be fixedly connected with, also can be removably connect, or the connection of one; Can be mechanical connection, also can be electrical connection; Can be directly be connected, also indirectly can be connected by intermediary, also can be the connection of two element internals.For a person skilled in the art, above-mentioned term concrete meaning in the present invention can be understood as the case may be.
Apart from outside definition, technology used in following examples and scientific terminology have the identical meanings generally understood with those skilled in the art of the invention.
Embodiment 1
A kind of electric-coagulation hemostatic device, comprise and insert handle 1, embedded pipe 2, electrode 3, conductive fiber aggregation 4, wherein insert handle 1 and there is tubular housing, embedded pipe 2 is embedded in described tubular housing, electrode 3 one end is connected to embedded pipe 2 bottom, conductive fiber aggregation 4 is the dough be wound by conductive fiber 10, conductive fiber aggregation 4 bondage is on described electrode 3, there is in described embedded pipe 2 the mutually isolated absorbing cavity in space 6 and loading chamber 7, absorbing cavity 6 lower end extends to described conductive fiber aggregation 4 place, insert on handle 1 lower sides and there is drug row mouth 21, loading chamber 7 is by described drug row mouth 21 and insertion handle 1 ft connection.
On the basis of above technical scheme:
Described conductive fiber 10 material is metallic fiber.
The conductive coating 11 on described conductive fiber 10 surface not exclusively covers conductive fiber 10 surface.
Described electrode 3 has three, is uniformly distributed along embedded pipe 2 lower circumference.
Described absorbing cavity 6 and loading chamber 7 are in a tubular form, absorbing cavity 6 upper end has the device providing negative pressure, thus the blood at conductive fiber aggregation 4 place can be got rid of in time, the drug row mouth 21 of loading chamber 7 and its underpart is used for adapting device entirety for delivering medicament haemostatic medicament and performs hemostasis, and described medicine is arbitrary external used medicine with haemostatic effect.
Embodiment 2
A kind of electric-coagulation hemostatic device, comprise and insert handle 1, embedded pipe 2, electrode 3, conductive fiber aggregation 4, wherein insert handle 1 and there is tubular housing, embedded pipe 2 is embedded in described tubular housing, electrode 3 one end is connected to embedded pipe 2 bottom, conductive fiber aggregation 4 is the dough be wound by conductive fiber 10, conductive fiber aggregation 4 bondage is on described electrode 3, there is in described embedded pipe 2 the mutually isolated absorbing cavity in space 6 and loading chamber 7, absorbing cavity 6 lower end extends to described conductive fiber aggregation 4 place, insert on handle 1 lower sides and there is drug row mouth 21, loading chamber 7 is by described drug row mouth 21 and insertion handle 1 ft connection.
On the basis of above technical scheme:
Described conductive fiber 10 material is carbon fiber.
The conductive coating 11 on described conductive fiber 10 surface not exclusively covers conductive fiber 10 surface.
Described electrode 3 has two, is uniformly distributed along embedded pipe 2 lower circumference.
The drug row mouth 21 of loading chamber 7 and its underpart is used for adapting device entirety for delivering medicament haemostatic medicament and performs hemostasis, described pharmaceutical formulation is as follows: 2 parts, Folium Photiniae (Folium Photiniae serrulatae) juice, Concretio Silicea Bambusae 2 parts, 1 part, Rhizoma Smilacis Bockii juice, 0.5 part, Folium Aloe juice, 0.5 part, Cera Flava, ginseng juice 0.5 part, pharmagel 0.5 part, 10 parts, water.
Embodiment 3
A kind of electric-coagulation hemostatic device, comprise and insert handle 1, embedded pipe 2, electrode 3, conductive fiber aggregation 4, wherein insert handle 1 and there is tubular housing, embedded pipe 2 is embedded in described tubular housing, electrode 3 one end is connected to embedded pipe 2 bottom, conductive fiber aggregation 4 is the dough be wound by conductive fiber 10, conductive fiber aggregation 4 bondage is on described electrode 3, there is in described embedded pipe 2 the mutually isolated absorbing cavity in space 6 and loading chamber 7, absorbing cavity 6 lower end extends to described conductive fiber aggregation 4 place, insert on handle 1 lower sides and there is drug row mouth 21, loading chamber 7 is by described drug row mouth 21 and insertion handle 1 ft connection.
On the basis of above technical scheme:
The conductive coating 11 on described conductive fiber 10 surface covers conductive fiber 10 surface completely.
The drug row mouth 21 of loading chamber 7 and its underpart is used for adapting device entirety for delivering medicament haemostatic medicament and performs hemostasis, and described pharmaceutical formulation is as follows: 3 parts, Folium Photiniae (Folium Photiniae serrulatae) juice, Concretio Silicea Bambusae 1 part, 2 parts, Rhizoma Smilacis Bockii juice, 1 part, Folium Aloe juice, 1 part, Cera Flava, ginseng juice 0.2 part, pharmagel 0.8 part, 10 parts, water.
Embodiment 4
A kind of electric-coagulation hemostatic device, comprise and insert handle 1, embedded pipe 2, electrode 3, conductive fiber aggregation 4, wherein insert handle 1 and there is tubular housing, embedded pipe 2 is embedded in described tubular housing, electrode 3 one end is connected to embedded pipe 2 bottom, conductive fiber aggregation 4 is the dough be wound by conductive fiber 10, conductive fiber aggregation 4 bondage is on described electrode 3, there is in described embedded pipe 2 the mutually isolated absorbing cavity in space 6 and loading chamber 7, absorbing cavity 6 lower end extends to described conductive fiber aggregation 4 place, insert on handle 1 lower sides and there is drug row mouth 21, loading chamber 7 is by described drug row mouth 21 and insertion handle 1 ft connection.
On the basis of above technical scheme:
The drug row mouth 21 of loading chamber 7 and its underpart is used for adapting device entirety for delivering medicament haemostatic medicament and performs hemostasis, described pharmaceutical formulation is as follows: 2.5 parts, Folium Photiniae (Folium Photiniae serrulatae) juice, Concretio Silicea Bambusae 1.5 parts, 1.5 parts, Rhizoma Smilacis Bockii juice, 0.6 part, Folium Aloe juice, 0.6 part, Cera Flava, ginseng juice 0.4 part, Os Gallus domesticus grass juice factor 0.15 part, throat grass juice factor 0.15 part, pharmagel 0.7 part, 10 parts, water.
Embodiment 5
Except ingredient, all the other technical characteristics are with embodiment 4.The present embodiment pharmaceutical formulation is as follows: 2.2 parts, Folium Photiniae (Folium Photiniae serrulatae) juice, Concretio Silicea Bambusae 1.6 parts, 1.7 parts, Rhizoma Smilacis Bockii juice, 0.8 part, Folium Aloe juice, 0.7 part, Cera Flava, ginseng juice 0.3 part, Os Gallus domesticus grass juice factor 0.12 part, throat grass juice factor 0.17 part, pharmagel 0.6 part, 10 parts, water.
Above embodiments of the invention have been described in detail, but described content is only preferred embodiment of the present invention, not in order to limit the present invention.All make in application range of the present invention any amendment, equivalent to replace and improvement etc., all should be included within protection scope of the present invention.

Claims (9)

1. an electric-coagulation hemostatic device, it is characterized in that comprising insertion handle, embedded pipe, electrode, conductive fiber aggregation, wherein insert handle and there is tubular housing, embedded pipe is embedded in described tubular housing, electrode one end is connected to embedded pipe bottom, conductive fiber aggregation is the dough be wound by conductive fiber, the bondage of conductive fiber aggregation is on described electrode, there is in described embedded pipe the mutually isolated absorbing cavity in space and loading chamber, absorbing cavity lower end extends to described conductive fiber aggregation place, insert on handle lower sides and there is drug row mouth, loading chamber is by described drug row mouth and insertion handle ft connection.
2. a kind of electric-coagulation hemostatic device according to claim 1, is characterized in that described conductive fiber material is metallic fiber.
3. a kind of electric-coagulation hemostatic device according to claim 1, is characterized in that described conductive fiber material is carbon fiber.
4. a kind of electric-coagulation hemostatic device according to claim 1, is characterized in that the conductive coating of described conductive fiber surfaces not exclusively covers conductive fiber surfaces.
5. a kind of electric-coagulation hemostatic device according to claim 1, is characterized in that described electrode has three, is uniformly distributed along embedded pipe lower circumference.
6. the Chinese medicine composition for electric-coagulation hemostatic device described in any one of Claims 1 to 5, it is characterized in that the composition comprising following weight portion: 2 ~ 3 parts, Folium Photiniae (Folium Photiniae serrulatae) juice, Concretio Silicea Bambusae 1 ~ 2 part, 1 ~ 2 part, Rhizoma Smilacis Bockii juice, 0.5 ~ 1 part, Folium Aloe juice, 0.5 ~ 1 part, Cera Flava, ginseng juice 0.2 ~ 0.5 part, pharmagel 0.5 ~ 0.8 part, 10 parts, water.
7. Chinese medicine composition according to claim 6, characterized by further comprising the Os Gallus domesticus grass juice factor of 0.1 ~ 0.2 part.
8. Chinese medicine composition according to claim 7, characterized by further comprising the throat grass juice factor of 0.1 ~ 0.2 part.
9. Chinese medicine composition according to claim 8, it is characterized in that described Chinese medicine composition is grouped into by the one-tenth of following weight portion: 2.5 parts, Folium Photiniae (Folium Photiniae serrulatae) juice, Concretio Silicea Bambusae 1.5 parts, 1.5 parts, Rhizoma Smilacis Bockii juice, 0.6 part, Folium Aloe juice, 0.6 part, Cera Flava, ginseng juice 0.4 part, Os Gallus domesticus grass juice factor 0.15 part, throat grass juice factor 0.15 part, pharmagel 0.7 part, 10 parts, water.
CN201510697111.7A 2015-10-19 2015-10-19 A kind of electric-coagulation hemostatic device and the Chinese medicine composition for the device Expired - Fee Related CN105193499B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510697111.7A CN105193499B (en) 2015-10-19 2015-10-19 A kind of electric-coagulation hemostatic device and the Chinese medicine composition for the device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510697111.7A CN105193499B (en) 2015-10-19 2015-10-19 A kind of electric-coagulation hemostatic device and the Chinese medicine composition for the device

Publications (2)

Publication Number Publication Date
CN105193499A true CN105193499A (en) 2015-12-30
CN105193499B CN105193499B (en) 2018-08-28

Family

ID=54941727

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510697111.7A Expired - Fee Related CN105193499B (en) 2015-10-19 2015-10-19 A kind of electric-coagulation hemostatic device and the Chinese medicine composition for the device

Country Status (1)

Country Link
CN (1) CN105193499B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110960316A (en) * 2019-12-19 2020-04-07 江志杰 Rapid hemostasis device for hepatobiliary surgery

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159207A (en) * 1997-07-31 2000-12-12 Yoon; Inbae Protected ablation method and apparatus
US7033356B2 (en) * 2002-07-02 2006-04-25 Gyrus Medical, Inc. Bipolar electrosurgical instrument for cutting desiccating and sealing tissue
CN1882289A (en) * 2003-11-21 2006-12-20 玛格戴恩医疗产品公司 Tuned return electrode with matching inductor
US20070276363A1 (en) * 1998-02-12 2007-11-29 Boris E. Paton Instrument and method for the end-to-end reconnection of intestinal tissues
CN201073341Y (en) * 2007-08-01 2008-06-18 同济大学 Electric knife head used for hemostasia
US20090082769A1 (en) * 2007-09-20 2009-03-26 Tyco Healthcare Group Lp Tissue Sealer and End Effector Assembly and Method of Manufacturing Same
CN203815577U (en) * 2014-01-21 2014-09-10 陈霞 Surgical hemostasis device
WO2014207640A1 (en) * 2013-06-27 2014-12-31 Paul Weber Apparatus, systems and methods for dissection and modification of tissues
CN104305180A (en) * 2014-10-09 2015-01-28 张璧云 Edible and applicable ingredient
CN104491561A (en) * 2015-01-16 2015-04-08 陈喆 Medicine used for treating pneumonia and preparation method of medicine
CN204971575U (en) * 2015-09-23 2016-01-20 何晏清 Electric -coagulation hemostatic device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN204468264U (en) * 2015-03-09 2015-07-15 上海市东方医院 The bipolar coagulation forceps that band attracts

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159207A (en) * 1997-07-31 2000-12-12 Yoon; Inbae Protected ablation method and apparatus
US20070276363A1 (en) * 1998-02-12 2007-11-29 Boris E. Paton Instrument and method for the end-to-end reconnection of intestinal tissues
US7033356B2 (en) * 2002-07-02 2006-04-25 Gyrus Medical, Inc. Bipolar electrosurgical instrument for cutting desiccating and sealing tissue
CN1882289A (en) * 2003-11-21 2006-12-20 玛格戴恩医疗产品公司 Tuned return electrode with matching inductor
CN201073341Y (en) * 2007-08-01 2008-06-18 同济大学 Electric knife head used for hemostasia
US20090082769A1 (en) * 2007-09-20 2009-03-26 Tyco Healthcare Group Lp Tissue Sealer and End Effector Assembly and Method of Manufacturing Same
WO2014207640A1 (en) * 2013-06-27 2014-12-31 Paul Weber Apparatus, systems and methods for dissection and modification of tissues
CN203815577U (en) * 2014-01-21 2014-09-10 陈霞 Surgical hemostasis device
CN104305180A (en) * 2014-10-09 2015-01-28 张璧云 Edible and applicable ingredient
CN104491561A (en) * 2015-01-16 2015-04-08 陈喆 Medicine used for treating pneumonia and preparation method of medicine
CN204971575U (en) * 2015-09-23 2016-01-20 何晏清 Electric -coagulation hemostatic device

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张大维: "芦荟凝胶对美容激光致皮肤创伤修复作用研究", 《中成药》 *
谷小燕: "鲜芦荟汁对血小板减少患者穿刺针眼止血效果观察", 《全科医生技能发展》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110960316A (en) * 2019-12-19 2020-04-07 江志杰 Rapid hemostasis device for hepatobiliary surgery

Also Published As

Publication number Publication date
CN105193499B (en) 2018-08-28

Similar Documents

Publication Publication Date Title
CN203597997U (en) Nail bin of anastomat and anastomat
CN105193499A (en) Electric coagulation hemostasis device and traditional Chinese medicine composition used for device
CN104225258B (en) A kind of Chinese medicine composition promoting wound healing
CN204500900U (en) A kind of surgical delivery device of Novel congenital heart disease interventional therapy
CN204971575U (en) Electric -coagulation hemostatic device
CN204293343U (en) A kind of intracavitary neoplasm interventional therapy equipment
CN203954089U (en) The portable secured arm support of operation
CN103948661B (en) Pharmaceutical composition and its application for treating gynecological disease, prostatic disorders or anorectal disease
CN208541652U (en) A kind of vaccine syringe with heat preservation and refrigerating function
CN209059420U (en) A kind of composite bipolar coagulation that band drips with suction function
CN104146257B (en) Biological reinforced cell nutritious element is preparing the application in AntiHIV1 RT activity functional food
CN208002887U (en) A kind of fly-cutting hemostasis high-frequency welding scalpel
CN208243586U (en) A kind of liver-and-gall surgery drag hook
CN206044721U (en) A kind of radio frequency temperature control therapeutic equipmentss for anorectal hemorrhoid treating
CN103549984A (en) Nail cabin of anastomat and anastomat
CN205146299U (en) Follow -on blood sampling test -tube rack
CN203988210U (en) Straight head hemostatic forceps
CN204542530U (en) A kind of Novel thighbone head medical bag
CN204072644U (en) The special fixing drag hook type of a kind of Novel gynecological is cut open the belly obstetric table
CN204683761U (en) A kind of novel cavity mirror electrosurgical coagulates device
CN103751555A (en) Dendrobium officinale patch with hemostatic function
CN204170150U (en) A kind of nano-cellulose dressing for the treatment of large-area burns
CN202920342U (en) Bipolar electric coagulation forceps
CN203944009U (en) Medical operation suction device head
CN208554303U (en) A kind of fixed device

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180828

Termination date: 20191019

CF01 Termination of patent right due to non-payment of annual fee